China Universal Asset Management Company’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.6K Buy
35,334
+1,085
+3% +$1K ﹤0.01% 489
2026
Q1
$20.8K Buy
34,249
+3,733
+12% +$3.88K ﹤0.01% 493
2025
Q4
$29.3K Buy
30,516
+2,756
+10% +$3.9K ﹤0.01% 478
2025
Q3
$48.3K Sell
27,760
-3,395
-11% -$6.65K ﹤0.01% 435
2025
Q2
$65.1K Buy
31,155
+5,346
+21% +$10.3K 0.01% 401
2025
Q1
$44K Sell
25,809
-1,473
-5% -$5.53K ﹤0.01% 425
2024
Q4
$138K Buy
27,282
+4,327
+19% +$21.4K 0.01% 360
2024
Q3
$125K Buy
22,955
+8,965
+64% +$59.1K 0.01% 340
2024
Q2
$67.2K Sell
13,990
-5,893
-30% -$30.7K 0.01% 334
2024
Q1
$61.8K Buy
19,883
+7,897
+66% +$26.6K 0.01% 402
2023
Q4
$34K Buy
11,986
+9,325
+350% +$23.9K 0.01% 398
2023
Q3
$7.8K Buy
2,661
+1,306
+96% +$4.32K ﹤0.01% 362
2023
Q2
$3.88K Sell
1,355
-43
-3% -$155 ﹤0.01% 391
2023
Q1
$4.32K Buy
1,398
+351
+34% +$998 ﹤0.01% 384
2022
Q4
$2.21K Buy
1,047
+82
+8% +$249 ﹤0.01% 366
2022
Q3
$3K Buy
+965
New +$3.7K ﹤0.01% 327

Other funds holding HUMA

China Universal Asset Management Company's HUMA Position: Q2 2026 in Review

China Universal Asset Management Company increased its Humacyte (HUMA) stake by 3.2% in Q2 2026, buying an estimated $1K and bringing the position to 35,334 shares worth $27.6K. The position accounts for ﹤0.01% of the portfolio, ranked #489.

China Universal Asset Management Company first reported a position in HUMA in Q3 2022 and has held it in 16 quarters since. The position peaked at $138K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • China Universal Asset Management Company held 35,334 shares of Humacyte worth $27.6K as of Q2 2026.
  • China Universal Asset Management Company bought 1,085 Humacyte shares in Q2 2026, an estimated $1K.
  • Humacyte made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #489 holding.
  • China Universal Asset Management Company first reported a position in Humacyte in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Humacyte position peaked at $138K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.